Skip to main content
SpringerLink
Log in

Optimizing General Management of Acute Variceal Bleeding in Cirrhosis

  • Portal Hypertension (JC Garica-Pagán, Section Editor)
  • Published:
Current Hepatology Reports Aims and scope Submit manuscript

Abstract

As soon as acute gastrointestinal bleeding is confirmed in patients with portal hypertension, treatment with vasoactive drugs and prophylactic antibiotics should be instituted. Once hemodynamic stability has been achieved, emergency endoscopy should be performed and endoscopic therapy (preferably with legation) should be carrier out when variceal bleeding is disclosed. It is advisable to maintain drug therapy for 5 days to prevent early rebleeding. When this treatment fails, TIPS should be considered. Balloon tamponade is indicated in patients with massive bleeding, as a bridge until definitive treatment could be instituted. Self-expanding metal stents are an alternative to tamponade which may even improve the outcomes. Recent data suggest that patients at high-risk of failure may benefit from invasive treatments such as early TIPS, while those with low-risk may do well with less intensive therapy including shorter administration of vasoactive drugs. However, these possibilities should be further investigated in future studies providing therapy according to stratification of risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Crooks C, Card TIM, West J. Reductions in 28-day mortality following hospital admission for upper gastrointestinal hemorrhage. Gastroenterology. 2011;141:62–70.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48:S68–92.

    Article  CAS  PubMed  Google Scholar 

  3. De Franchis R. Evolving consensus in portal hypertension. Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.

    Article  PubMed  Google Scholar 

  4. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–32.

    Article  CAS  PubMed  Google Scholar 

  5. McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypotesis. Gut. 1995;36:100–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Abraldes JG, Villanueva C, Bañares R, et al. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48:229–36.

    Article  PubMed  Google Scholar 

  7. Villanueva C, Balanzo J. Variceal bleeding: pharmacological treatment and prophylactic strategies. Drugs. 2008;68:2303–24.

    Article  CAS  PubMed  Google Scholar 

  8. Altraif I, Handoo FA, Aljumah A, et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double-blind, placebo-controlled trial. Gastrointest Endosc. 2011;73:245–50.

    Article  PubMed  Google Scholar 

  9. Chen PH, Chen WC, Hou MC, et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol. 2012;57:1207–13.

    Article  PubMed  Google Scholar 

  10. Myburgh JA. Fluid resuscitation in acute illness. Time to reappraise the basics. N Engl J Med. 2011;364:2543–4.

    Article  CAS  PubMed  Google Scholar 

  11. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology. 1986;90:1232–40.

    CAS  PubMed  Google Scholar 

  12. Castañeda B, Morales J, Lionetti R, Moitinho E, Andreu V, Pérez-del-Pulgar S, et al. Effects of blood volume restitution following a portal hypertensive–related bleeding in anesthetized cirrhotic rats. Hepatology. 2001;33:821–5.

    Article  PubMed  Google Scholar 

  13. Villanueva C, Ortiz J, Miñana J, Soriano G, Sàbat M, Boadas J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001;121:110–7.

    Article  CAS  PubMed  Google Scholar 

  14. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21. A RCT that compare a restrictive vs. a liberal transfusion strategy in patients with acute gastrointestinal bleeding. The study shows that the restrictive policy confers benefits, including an improvement of survival, in addition to lower transfusional requirements.

    Article  CAS  PubMed  Google Scholar 

  15. Barr PJ, Bailie KEM. Transfusion thresholds in FOCUS. N Engl J Med. 2011;365:2532–3.

    Article  CAS  PubMed  Google Scholar 

  16. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–17.

    Article  PubMed  Google Scholar 

  18. Blair SD, Janvrin SB, McCollum CN, Greenhalgh. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 1986;73:783–5.

    Article  CAS  PubMed  Google Scholar 

  19. Hearnshaw SA, Logan A, Palmer KR, Card TR, Travis SPL, Murphy MF. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2010;32:215–24.

    Article  CAS  PubMed  Google Scholar 

  20. Duggan JM. Transfusion in gastrointestinal haemorrhage — if, when and how much? Aliment Pharmacol Ther. 2001;15:1109–13.

    Article  CAS  PubMed  Google Scholar 

  21. Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152:101–13.

    Article  PubMed  Google Scholar 

  22. Burroughs AK. General management of the cirrhotic patient with acute variceal bleeding. In: De Franchis R, editor. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapy startegies. Oxford: Blackwell Science Limited; 2001. p. 135–42.

    Google Scholar 

  23. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation and variceal bleeding in cirrhosis. Gut. 2005;54:556–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Hou MC et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746–53.

    Article  CAS  PubMed  Google Scholar 

  25. Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–61.

    Article  CAS  PubMed  Google Scholar 

  26. Fernández J, Ruiz del Arbol L, Gómez C, et al. Norfloxacin vs Ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131:1049–56.

    Article  PubMed  Google Scholar 

  27. Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001;34:671–6.

    Article  CAS  PubMed  Google Scholar 

  28. Escorsell A, Ginès A, Llach J, et al. Increasing intra-abdominal pressure increases pressure, volume and wall tension in esophageal varices. Hepatology. 2002;36:936–40.

    Article  PubMed  Google Scholar 

  29. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147–56. A paper revising the function of both procoagulant and anticuiagulant drivers in patients with cirrhosis and showing that prothrombin-time test and related tests are not adequate to assess the risk of hemorrhage in such patients as it reflects liver dysfunction but not bleeding risk.

    Article  CAS  PubMed  Google Scholar 

  30. Bosch J, Thabut D, Bendtsen F, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology. 2004;127:1123–30.

    Article  CAS  PubMed  Google Scholar 

  31. Bosch J, Thabut D, Albillos A, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008;47:1604–14.

    Article  CAS  PubMed  Google Scholar 

  32. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;350:1495–9.

    Article  CAS  PubMed  Google Scholar 

  33. Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus glyceryl trinatre to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet. 1995;346:865–8.

    Article  CAS  PubMed  Google Scholar 

  34. D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology. 2003;124:1277–91.

    Article  PubMed  Google Scholar 

  35. Azam Z, Hamid S, Jafri W, et al. Short course adjuvant terlipressin in acute variceal bleeding: a randomized double blind dummy controlled trial. J Hepatol. 2012;56:819–24.

    Article  CAS  PubMed  Google Scholar 

  36. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475–505.

    Article  PubMed  Google Scholar 

  37. Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther. 2003;17:53–64.

    Article  CAS  PubMed  Google Scholar 

  38. Escorsell A, Ruiz-del-Arbol L, Planas R, Albillos A, Banares R, Cales P, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology. 2000;32:471–6.

    Article  CAS  PubMed  Google Scholar 

  39. Abraldes JG, Bosch J. Somatostatin and analogues in portal hypertension. Hepatology. 2002;35:1305–12.

    Article  CAS  PubMed  Google Scholar 

  40. Escorsell A, Bordas JM, del Arbol LR, Jaramillo JL, Planas R, Banares R, et al. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group. J Hepatol. 1998;29:779–88.

    Article  CAS  PubMed  Google Scholar 

  41. Bañares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35:609–15.

    Article  PubMed  Google Scholar 

  42. Escorsell A, Bandi JC, Andreu V, Moitinho E, Garcia-Pagan JC, Bosch J, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001;120:161–9.

    Article  CAS  PubMed  Google Scholar 

  43. Villanueva C, Planella M, Aracil C, et al. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonreponders to the usual somatostatin dose. Am J Gastroenterol. 2005;100:624–30.

    Article  CAS  PubMed  Google Scholar 

  44. Moitinho E, Planas R, Bañares R, Albillos A, Ruiz-del-Arbol L, Galvez C, et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001;35:712–8.

    Article  CAS  PubMed  Google Scholar 

  45. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995;123:280–7.

    Article  CAS  PubMed  Google Scholar 

  46. Villanueva C, Ortiz J, Sabat M, et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology. 1999;30:384–9.

    Article  CAS  PubMed  Google Scholar 

  47. De Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis. 1999;19:439–55.

    Article  PubMed  Google Scholar 

  48. Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis. 2005;9:685–713.

    Article  PubMed  Google Scholar 

  49. Lo GH, Lai KH, Cheng JS, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology. 1997;25:1101–4.

    Article  CAS  PubMed  Google Scholar 

  50. Villanueva C, Piqueras M, Aracil C, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endioscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45:560–7.

    Article  PubMed  Google Scholar 

  51. Garcia-Tsao G, Sanyal A, Grace ND, Carey W, Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–38.

    Article  CAS  PubMed  Google Scholar 

  52. Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis. 1999;19:457–73.

    Article  CAS  PubMed  Google Scholar 

  53. Bureau C, García-Pagán JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.

    Article  PubMed  Google Scholar 

  54. Avgerinos A, Armonis A. Balloon tamponade technique and efficacy in variceal haemorrhage. Scand J Gastroenterol Suppl. 1994;207:11–6.

    Article  CAS  PubMed  Google Scholar 

  55. Hubmann R, Bodlaj G, Czompo M, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38:896–901.

    Article  CAS  PubMed  Google Scholar 

  56. Wright G, Lewis H, Hogan B, et al. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc. 2010;71:71–8.

    Article  PubMed  Google Scholar 

  57. Escorsell A, Cardenas A, Pavel O, Morillas RM, Albillos A, Llop E, et al. Self-expandable esophageal metal stent vs balloon tamponade in esophageal variceal bleeding refractory to medical and endoscopic treatment: a multicenter randomized controlled trial. Hepatology. 2013;58:1386–87A.

    Google Scholar 

  58. Burroughs AK, Patch D. Management of variceal hemorrhage in cirrhotic patients. Gut. 2001;48:738–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Ready JB, Robertson AD, Goff JS, Rector WG. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991;100:1403–10.

    CAS  PubMed  Google Scholar 

  60. Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117(3):626–31.

    Article  CAS  PubMed  Google Scholar 

  61. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793–801.

    Article  PubMed  Google Scholar 

  62. García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–9.

    Article  PubMed  Google Scholar 

  63. Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated metaanalysis. Scand J Gastroenterol. 2002;37:249–52.

    Article  CAS  PubMed  Google Scholar 

  64. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35:385–92.

    Article  PubMed  Google Scholar 

  65. Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412–4198.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Candid Villanueva and Àngels Escorsell declares that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain

    Càndid Villanueva

  2. ICU-Liver Unit, Hospital Clínic, Barcelona, Spain

    Àngels Escorsell

  3. Servei de Patologia Digestiva, Gastrointestinal Bleeding Unit, Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Avgda. Sant Antoni M Claret, 167, 08025, Barcelona, Spain

    Càndid Villanueva

Authors
  1. Càndid Villanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Àngels Escorsell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Càndid Villanueva.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Villanueva, C., Escorsell, À. Optimizing General Management of Acute Variceal Bleeding in Cirrhosis. Curr Hepatology Rep 13, 198–207 (2014). https://doi.org/10.1007/s11901-014-0241-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-014-0241-7

Keywords

Search

Navigation